Insider Trading History of De Witte Jan

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of De Witte Jan since 2023. This trader's CIK number is 1776929. At the time of last reporting, De Witte Jan was the Director of Resmed Inc. (stock ticker symbol RMD). Also see all insider trading activities at Resmed Inc.

Note that in the past De Witte Jan also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Integra Lifesciences Holdings Corp (IART) by De Witte Jan

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2024 IART 0 $0 0 $0 10,962 $0
2023 IART 7,792 $299,984 0 $0 9,814 $0

Yearly summary of insider trading at Resmed Inc (RMD) by De Witte Jan

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 RMD 0 $0 2,000 $486,940 0 $0
2024 RMD 0 $0 1,156 $276,636 0 $0


Insider trading activities at 2 companies by De Witte Jan:

1. Integra Lifesciences Holdings Corp (IART)

2. Resmed Inc (RMD)

Table 1. Insider trading of Integra Lifesciences Holdings Corp (IART) by De Witte Jan

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2024-11-01 IART Option Ex 9,814 .00 0
2024-03-11 IART Option Ex 205 .00 0
2024-03-10 IART Option Ex 346 .00 0
2024-01-18 IART Option Ex 597 .00 0
2023-11-01 IART Option Ex 9,814 .00 0
2023-06-01 IART Buy 7,792 38.50 299,984

Table 2. Insider trading of Resmed Inc (RMD) by De Witte Jan

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-05-20 RMD Sale 2,000 243.47 486,940
2024-11-12 RMD Sale 796 248.81 198,052
2024-05-15 RMD Sale 360 218.29 78,584

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by De Witte Jan (Director of Resmed Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.